SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $91.33 | 52-week high | $105.47 |
Prev. close | $91.41 | 52-week low | $81.14 |
Day low | $90.97 | Volume | 9,041,400 |
Day high | $93.12 | Avg. volume | 9,221,803 |
50-day MA | $92.25 | Dividend yield | 0.15% |
200-day MA | $95.24 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Biotechnology Select Industry Index |
Asset Class | Equity |
Sector | Biotech |
Assets Under Management (AUM) | 6.07M |
Net Asset Value (NAV) | $91.40 |
Options? | Yes |
Total Holdings | 144 |
XBI Top Holdings
Symbol | Company | % of Total |
GILD | GILEAD SCIENCES INC | 2.74% |
ABBV | ABBVIE INC | 2.65% |
AMGN | AMGEN INC | 2.57% |
INSM | INSMED INC | 2.53% |
ALNY | ALNYLAM PHARMACEUTICALS INC | 2.49% |
UTHR | UNITED THERAPEUTICS CORP | 2.44% |
NTRA | NATERA INC | 2.44% |
VRTX | VERTEX PHARMACEUTICALS INC | 2.36% |
BMRN | BIOMARIN PHARMACEUTICAL INC | 2.33% |
INCY | INCYTE CORP | 2.31% |
XBI Price Returns
1-mo | 3.82% |
3-mo | -2.85% |
6-mo | -8.78% |
1-year | N/A |
3-year | 2.34% |
5-year | -6.25% |
YTD | 1.41% |
2024 | 1.01% |
2023 | 7.60% |
2022 | -25.87% |
2021 | -20.45% |
2020 | 48.33% |
XBI Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |